
Aurélie Rose De Rus Jacquet
Chercheuse universitaire
Axe Neurosciences
Publications
View all-
article Tambe MA, de Rus Jacquet A, Strathearn KE, Hensel JA, Colón BD, Chandran A, Yousef GG, Grace MH, Ferruzzi MG, Wu Q, Simon JE, Lila MA, Rochet JC
Protective Effects of Polyphenol-Rich Extracts against Neurotoxicity Elicited by Paraquat or Rotenone in Cellular Models of Parkinson’s Disease
Antioxidants (Basel) 12 (7), 2023.
-
article de Rus Jacquet A, Tancredi JL, Lemire AL, DeSantis MC, Li WP, O'Shea EK
The LRRK2 G2019S mutation alters astrocyte-to-neuron communication via extracellular vesicles and induces neuron atrophy in a human iPSC-derived model of Parkinson’s disease
Elife 10 2021.
-
article de Rus Jacquet A
Preparation and Co-Culture of iPSC-Derived Dopaminergic Neurons and Astrocytes
Curr Protoc Cell Biol 85 (1), 2019.
Projects
- Fonds de démarrage pour chercheurs en debut de carrière - Bourse de recrutement étudiant, from 2023-07-01 to 2028-06-30
- Fonds de démarrage - Nouveau chercheur, from 2023-07-01 to 2027-06-30
- Maladie de Parkinson et Premiers Peuples : étude évaluative des besoins neurologiques, from 2023-09-01 to 2026-03-31
- Targeting the blood-brain immune axis to prevent dissemination and progression of Parkinson’s disease, from 2023-09-25 to 2025-09-24
- Crosstalk at the blood-brain barrier: new insights into Parkinson's disease, from 2023-08-01 to 2026-06-30
- Entre immunité et neurodégénérescence : le rôle des cellules gliales dans la maladie de Parkinson, from 2024-07-01 to 2028-06-30
- Institut sur la nutrition et les aliments fonctionnels (INAF), from 2024-04-01 to 2030-03-31
- Dynamic regulation of the neuroimmune response: role of LRRK2 and extracellular vesicles in astrocyte-microglia crosstalk, from 2024-04-01 to 2029-03-31
- Generation of iPSCs with an Indigenous ancestry to promote inclusion of North America’s First Peoples in Parkinson’s disease research, from 2024-05-01 to 2026-04-30
- Dynamic regulation of the neuroimmune response: role of LRRK2 and extracellular vesicles in astrocyte-microglia crosstalk, from 2024-04-01 to 2029-03-31
- Alpha-synuclein at the brain vasculature: a new disease mechanism and drug target, from 2024-08-01 to 2027-07-31
- Organ-on-chip: la prochaine génération de plateforme de modélisation des maladies et de criblage des médicaments, from 2024-12-01 to 2026-11-30
- Developing vascularized brain-on-chip technologies: the next frontier in euroscientific research, from 2024-09-01 to 2026-08-31
- Entre immunité et neurodégénérescence : le rôle des cellules gliales dans la maladie de Parkinson, from 2024-07-01 to 2028-06-30
- Implementing iPSC-derived brain-chip technologies to evaluate the contributions of environmental toxins to Parkinson’s disease, from 2024-11-01 to 2026-03-31
- Elucidating the role of the peripheral-brain immune axis in Parkinson's disease, from 2025-02-20 to 2025-08-06
- Étude de la sélénonéine en tant que nouveau biomarqueur nutritionnel et agent thérapeutique dans les maladies neurodégénératives, from 2024-12-18 to 2026-03-31
- Institut sur la nutrition et les aliments fonctionnels (INAF), from 2017-04-01 to 2024-03-31
- Crosstalk at the blood-brain barrier: new insights into Parkinson's disease, from 2022-06-30 to 2023-07-31
- Blueberry polyphenol metabolites: biodistribution and mechanisms of protection at the blood-brain barrier, from 2023-08-25 to 2025-03-31
- The contributions of plasma composition to neurovascular dysfunction in Parkinson's disease, from 2025-01-20 to 2025-06-20